Skip to main navigation Skip to search Skip to main content

A factor IX-deficient mouse model for hemophilia B gene therapy

  • LL Wang
  • , M Zoppe
  • , TM Hackeng
  • , JH Griffin
  • , Kuo-Fen Lee
  • , IM Verma

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

We have generated a mouse where the clotting factor IX (FIX) gene has been disrupted by homologous recombination. The FIX nullizygous (-/-) mouse was devoid of factor IX antigen in plasma, Consistent with the bleeding disorder, the factor IX coagulant activities for wild-type (+/+), heterozygous (+/-), and homozygous (-/-) mice were 92%, 53%, and

Original languageEnglish
Pages (from-to)11563-11566
Number of pages4
JournalProceedings of the National Academy of Sciences of the United States of America
Volume94
Issue number21
DOIs
Publication statusPublished - 14 Oct 1997
Externally publishedYes

Keywords

  • TRANSPLANTATION
  • ADENOVIRUS
  • LONG
  • DOGS
  • MICE

Fingerprint

Dive into the research topics of 'A factor IX-deficient mouse model for hemophilia B gene therapy'. Together they form a unique fingerprint.

Cite this